Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
130.00
+6.50 (5.26%)
Aug 15, 2025, 2:31 PM CST

Syngen Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
279.44240.21274.83321.24237.77215.55
Upgrade
Depreciation & Amortization
120.92114.4199.2986.3181.2776.07
Upgrade
Other Amortization
0.270.270.180.190.130.6
Upgrade
Loss (Gain) From Sale of Assets
0.130.150.280.210.630.21
Upgrade
Asset Writedown & Restructuring Costs
----1.81-
Upgrade
Loss (Gain) From Sale of Investments
0.490.49-0.02-0.21-0.980.35
Upgrade
Loss (Gain) on Equity Investments
0.425.32-36.08-26.64-14.81-
Upgrade
Provision & Write-off of Bad Debts
-5.856.92-8.5817.820.33-1.77
Upgrade
Other Operating Activities
25.23-5.3712.2436.6733.37-2.13
Upgrade
Change in Accounts Receivable
-77.1-22.2990.02-101.12-13.1-51.46
Upgrade
Change in Inventory
-33.7-1.191.98-98.11-41.33-51.5
Upgrade
Change in Accounts Payable
19.3725.820.49-62.1257.7812.1
Upgrade
Change in Unearned Revenue
-2.814.813.310.184.58-0.66
Upgrade
Change in Other Net Operating Assets
50.67-21.48-52.82103.07-10.9422.84
Upgrade
Operating Cash Flow
377.47348.04415.13277.48336.5220.2
Upgrade
Operating Cash Flow Growth
1.40%-16.16%49.60%-17.54%52.81%-13.73%
Upgrade
Capital Expenditures
-51.41-60.21-91.9-584.27-61.67-272.75
Upgrade
Sale (Purchase) of Intangibles
-14.39-4.13-1.91-0.44--0
Upgrade
Investment in Securities
--20---273.84-
Upgrade
Other Investing Activities
-0.01-0.190.12-0.33-0.570.69
Upgrade
Investing Cash Flow
-65.8-84.53-93.68-585.05-336.08-272.06
Upgrade
Short-Term Debt Issued
-25028066050235
Upgrade
Long-Term Debt Issued
--106.4913250-
Upgrade
Total Debt Issued
260250386.49792100235
Upgrade
Short-Term Debt Repaid
--330-430-430-100-185
Upgrade
Long-Term Debt Repaid
--73.63-21.67-14.95-14.02-12.67
Upgrade
Total Debt Repaid
-484.15-403.63-451.67-444.95-114.02-197.67
Upgrade
Net Debt Issued (Repaid)
-224.15-153.63-65.17347.06-14.0237.33
Upgrade
Common Dividends Paid
-135.5-135.5-135.5-108.4-94.85-81.3
Upgrade
Other Financing Activities
0.110.050.140.1--0.02
Upgrade
Financing Cash Flow
-359.54-289.09-200.54238.75-108.88-43.99
Upgrade
Foreign Exchange Rate Adjustments
0.110.62-0.080.06-0.16-0.12
Upgrade
Net Cash Flow
-47.76-24.96120.84-68.75-108.62-95.98
Upgrade
Free Cash Flow
326.06287.83323.23-306.79274.83-52.55
Upgrade
Free Cash Flow Growth
16.32%-10.95%----
Upgrade
Free Cash Flow Margin
15.35%14.29%17.59%-15.89%18.68%-4.01%
Upgrade
Free Cash Flow Per Share
12.0110.6111.91-11.3110.13-1.94
Upgrade
Cash Interest Paid
7.629.358.844.893.22.46
Upgrade
Cash Income Tax Paid
62.4586.6875.360.1528.8755.18
Upgrade
Levered Free Cash Flow
253.48200.8248.25-368.73240.8-108.78
Upgrade
Unlevered Free Cash Flow
258.15206.6253.78-365.56242.8-107.24
Upgrade
Change in Working Capital
-43.56-14.3672.99-158.11-3.02-68.68
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.